NovaBridge Biosciences (NBP) — Cash Flow Reinvestment Rate

Latest as of September 2025: 0.00x

NovaBridge Biosciences (NBP) has a Cash Flow Reinvestment Rate of 0.00x as of September 2025, reinvesting $41.00 (capex $41.00 ) from operating cash flow of $13.15 Million. Check NovaBridge Biosciences cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

$41.00
Capex + Investments

Operating Cash Flow

$13.15 Million
USD

Capital Expenditures

$41.00
USD

NovaBridge Biosciences Cash Flow Reinvestment Rate (2020–2020)

Historical reinvestment intensity for NovaBridge Biosciences across 1 annual periods. Explore NovaBridge Biosciences (NBP) long-term investment share to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for NovaBridge Biosciences (2020–2020)

Year-by-year capital reinvestment analysis for NovaBridge Biosciences. For live market cap and broader valuation context, see NovaBridge Biosciences (NBP) market capitalisation.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2020 0.02x $8.01 Million $433.56 Million $8.01 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow